First Generic GLP-1 Injection OK'd for Weight Loss

(MedPage Today) — The FDA approved the first-ever generic form of a GLP-1 receptor agonist specifically indicated for weight loss, Teva Pharmaceuticals announced Thursday.
The generic form of liraglutide (Saxenda) is indicated for adults with…

Source link : https://www.medpagetoday.com/primarycare/obesity/117201

Author :

Publish date : 2025-08-28 18:26:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

First Generic GLP-1 Injection OK’d for Weight Loss

Can a Keto Diet be the GLP-1 of Psychiatry?

Departing CDC Officials Say Monarez’s Firing Was the Final Straw

Related Posts

Young-Onset Dementia Linked to Sharply Increased Death Risk

High Fluid Rates May Raise Inflammation Risk in Pancreatitis

Racial Variation in Opioid Prescribing in US Nursing Homes

What to Know About Dick Cheney’s Heart Trouble and Eventual Transplant

FDA Approves IV Antibiotic for Complicated UTIs

Deaf Culture Education Is Missing From Medical School Curriculums

Young-Onset Dementia Linked to Sharply Increased Death Risk

High Fluid Rates May Raise Inflammation Risk in Pancreatitis

Racial Variation in Opioid Prescribing in US Nursing Homes

What to Know About Dick Cheney’s Heart Trouble and Eventual Transplant

FDA Approves IV Antibiotic for Complicated UTIs

Deaf Culture Education Is Missing From Medical School Curriculums

Preterm Babies May Safely Start Full Milk Feeds on Day 1

Voiceprints Detect Early Alzheimer’s; Leucovorin Guidance Issued; CTE and DNA Damage

Categories

Archives